Incyte Corp
INCY
Equity
ISIN null / Valor 134791
NASDAQ (2026-03-20)
USD 90.78-2.33%
Incyte Corp
UMushroom community rating:
About company
Incyte Corp is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for cancer and other diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
49.9%1Y
22.3%3Y
14.4%5Y
Performance
35.3%1Y
30.8%3Y
29.3%5Y
Volatility
18067 M
Market cap (USD)
4,388,758
Daily traded volume (Shares)
68.77 / 67.76
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
